Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.74 +0.01 (+0.14%)
As of: Aug 21, 2026 · 2:31 PM EDT

Drugs Made In America Acquisition (DMAA) Total Current Liabilities (2024 - 2025)

Drugs Made In America Acquisition's (DMAA) quarterly Total Current Liabilities came in at $376172.0 in Q4 2025, down 52.72% YoY from $795669.0 in Q4 2024, and down 17.62% on a QoQ basis from $456611.0 in Q3 2025.

Drugs Made In America Acquisition (DMAA) Total Current Liabilities (2024 - 2025) Analysis & Trends

Drugs Made In America Acquisition (DMAA) has 2 years of Total Current Liabilities data on file, last reported at $376172.0 in Q4 2025.

  • Quarterly Total Current Liabilities fell 52.72% year-over-year to $376172.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $376172.0 (down 52.72% YoY) and the FY2025 annual result came in at $376172.0, down 52.72% from the prior year.
  • Total Current Liabilities slipped to $376172.0 in Q4 2025, from $456611.0 in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $795669.0 in Q4 2024 to a low of $301441.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 146,923.00
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 281,435.00
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 644,574.00
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - -
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 2.38 Mn
6 Aldel Financial 397.49 Mn 397.49 Mn - 20,057.00
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 38,850.00
8 Gores Holdings X 385.06 Mn 384.87 Mn - 3.69 Mn
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 22.16 Mn
10 Drugs Made In America Acquisition 215.82 Mn 215.82 Mn - 2.94 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 376,172.00
Sep 30, 2025 456,611.00
Jun 30, 2025 301,441.00
Mar 31, 2025 347,369.00
Dec 31, 2024 795,669.00